Trials / Recruiting
RecruitingNCT06516432
Parasternal Blockade and Serum Lactate in Cardiac Surgery
Serum Lactate in the Application of Parasternal Blockade in Trans and Post Anesthetic Stages in Cardiac Surgery
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 86 (estimated)
- Sponsor
- Instituto Mexicano del Seguro Social · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Serum lactate level is a key indicator of tissue perfusion. Parasternal blockade is associated with reduced postoperative inflammatory response by inhibiting stress response, leading to better outcomes. Elevated lactate levels help identify patients at risk of postoperative morbidity and mortality. This analytical cross-sectional study evaluated the association between parasternal blockade and serum lactate levels in patients undergoing elective cardiac surgery in 2022 at Specialty Hospital CMNO. Patients with and without parasternal block were compared for changes in serum lactate levels during and after anesthesia within the first 24 hours.
Detailed description
Background: Serum lactate level is a crucial indicator of tissue perfusion. Parasternal blockade has been related to a reduction of the postoperative inflammatory response, by inhibition of the stress response, leading to a better prognosis. Increased lactate level is a useful parameter in the identification of patients at risk of postoperative morbidity and mortality. Objective: To evaluate the association between parasternal blockade and serum lactate level in patients undergoing cardiac surgery, both trans and postanesthesia. Materials and Methods: Analytical cross-sectional study in adult patients undergoing elective cardiac surgery during the year 2022 in Specialty Hospital CMNO, patients with and without application of parasternal block were analyzed, and it was associated with changes in serum lactate level trans and post anesthesia in the first 24 hours. Approval registration: R-2023-1301-024.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Parasternal block | In the case-control groups, patients with elevated serum lactate levels above 2 mmol/L and those who remained below this limit will be identified. |
| PROCEDURE | Requirement of total dose regarding fentanyl | In case-control groups, obtain measurement of total postoperative fentanyl requirement. |
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
- First posted
- 2024-07-24
- Last updated
- 2024-07-24
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT06516432. Inclusion in this directory is not an endorsement.